Gilead Sciences, Inc. Common Stock Earnings Dividend

Gilead Sciences, Inc. Common Stock’s revenue jumped 10.2% since last year same period to $7803Mn in the Q2 2026. On a quarterly growth basis, Gilead Sciences, Inc. Common Stock has generated 12.11% jump in its revenue since last 3-months.

Gilead Sciences, Inc. Common Stock’s net profit fell -635.51% since last year same period to $-10496Mn in the Q2 2026. On a quarterly growth basis, Gilead Sciences, Inc. Common Stock has generated -619.35% fall in its net profits since last 3-months.

Gilead Sciences, Inc. Common Stock’s net profit margin fell -585.96% since last year same period to -134.51% in the Q2 2026. On a quarterly growth basis, Gilead Sciences, Inc. Common Stock has generated -563.24% fall in its net profit margins since last 3-months.

Gilead Sciences, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at 2.15 - a 130.41% jump from last quarter’s estimates.

Gilead Sciences, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at 2.15.

Gilead Sciences, Inc. Common Stock’s earning per share (EPS) fell -435.82% since last year same period to -6.75 in the Q2 2026. This indicates that the Gilead Sciences, Inc. Common Stock has generated -435.82% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Gilead Sciences, Inc. Common Stock declared 0.82 dividend per share during the earnings announcement for Q2 2026.